$VSEE

VSee Health (NASDAQ:VSEE) said it signed a non-binding letter of intent to acquire healthcare technology and operating assets for a vertically integrated healthcare commerce platform. VSee estimates the deal value at about $42 million, with target annualized revenue over $35 million and about $7 million EBITDA, unaudited. Closing depends on due diligence, definitive agreements, and approvals.

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 vseeex10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 30, 2026, by and between VSee Health, Inc. , a Delaware corporation, with headquarters located at 980 N Federal Hwy, #304, Boca

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for a vertically integrated healthcare commerce platform. The target assets have an unaudited run rate above $35 million and EBITDA around $7 million. VSee expects a quick close without initial shareholder dilution, subject to due diligence and definitive agreements.

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for $42 million. The target assets have an unaudited run rate above $35 million in annualized revenue and about $7 million in EBITDA. VSee will conduct due diligence and negotiate definitive terms; no deal is assured.

VSee Health (NASDAQ:VSEE) said its board has initiated a comprehensive strategic review to pursue alternatives such as partnerships, mergers, acquisitions, licensing, and capital formation. The company is in late-stage discussions with potential strategic partners, aiming to accelerate growth and maximize long-term shareholder value. No transaction is assured.

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001864531 0001864531 2026-07-21 2026-07-21 0001864531 VSEE:CommonStock0.0001ParValuePerShareMember 2026-07-21 2026-07-21 0001864531 VSEE:WarrantsWhichEntitlesHolderToPurchaseOne1ShareOfCommonStockAtPriceOf11.50PerWholeShareMember 2026-07-21 2026-07-21 iso4217:USD xbrli:sha

VSee Health, Inc. (NASDAQ:VSEE) said its board approved a proposed reverse stock split of up to 80-for-1, subject to regulatory and shareholder approvals, to support Nasdaq listing. The company terminated a previously announced standby equity purchase agreement and said it has no active equity financing facility expected to cause near-term dilution. As of July 6, 2026, it had 55,679,813 shares outstanding.

VSee Health (NASDAQ:VSEE) issued a shareholder update from CEO Dr. Imoigele Aisiku. The company says it has shifted resources to its iDoc TeleHealth solutions after divesting lab operations, expanding hospital adoption from 3 to 58. Management expects iDoc to reach profitability within 12 months, citing lower costs and improved operating leverage.

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.4 5 vseeex10-4.htm EXHIBIT 10.4 Exhibit 10.4 THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,